About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT02338687

Low Dose Calcium to Prevent Preeclampsia

The purpose of this study is to assess, in pregnant women with calcium-poor diets, what is the effectiveness of low-dose (500 mg/day) calcium supplements associated with an educational intervention, c...

Lead sponsor: Federal University of São Paulo•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Federal University of São Paulo

Collaborators

PPSUS (Programa Pesquisa para o SUS: gestão compartilhada em saúde)
FAPEAM (Fundação de Amparo a Pesquisa do Estado do Amazonas)
Universidade Federal do Amazonas

Age

10 - 55 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Capacity to understand verbal and visual instructions
•Gestational age 16 - 20 weeks
•Live fetus

Exclusion Criteria

•Hyperparathyroidism or other contra-indication to calcium supplementation
•Gastrointestinal diseases or conditions that may interfere with calcium absorption (e.g. bariatric surgery, cancer, chronic colitis)
•Use of medications that may interfere with calcium absorption (e.g. corticosteroids, thiazides, thyroid hormones)
•Women already taking calcium supplements or daily antacids at recruitment

Related studies

RECRUITINGPhase 3

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

NCT06408181 · Pre-Eclampsia, Pregnancy Loss

Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia

NCT07245056 · Pre-Eclampsia, Hippocampus

RECRUITINGPhase 1

Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History

NCT06821685 · Abortion, Habitual, Infertility Unexplained, and more

Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women

NCT04520048 · Hypertension Disorders in Pregnancy, Gestational Hypertension, and more

Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.

NCT06122220 · Pre-Eclampsia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 12, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment1,040

Start dateOct 2014

Last updatedOct 12, 2023

Condition

Pre-Eclampsia Hypertension, Pregnancy-Induced Dietary Calcium Deficiency

Locations shown

Universidade Federal do Amazonas

Manaus, Amazonas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 12, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions